Kiran Mazumdar Shaw Bio, Wiki, Age, Family, Husband, Net Worth

Kiran Mazumdar Shaw Biography

Kiran Mazumdar-Shaw is famously known as an Indian billionaire entrepreneur. In addition, she is the executive chairperson and founder of Biocon Limited and also Biocon Biologics Limited, a biotechnology company located in Bangalore, India and also the former chairperson of Indian Institute of Management, Bangalore.

How old is Kiran Mazumdar Shaw? – Age

Mazumdar Shaw is 70 years old as of 2024. She was born on 23 March 1953, in Bengaluru, India, where she also grew up.

How tall is Kiran Mazumdar Shaw? – Height

He stands at a height of 5 feet 3 inches (1.61 m) tall.

Kiran Mazumdar Shaw’s Mother, Father – Family

Mazumdar Shaw was born to his loving parents, in Bangalore, Karnataka state, to Gujarati parents.

Kiran Mazumdar Shaw’s Education

She got educated at Bangalore’s Bishop Cotton Girl’s High School, later graduated in 1968. In addition, she attended Mount Carmel College, Bangalore, a women’s college getting pre-university courses as an affiliate of Bangalore University.

Is Kiran Mazumdar Shaw Married? – Husband

The Indian billionaire entrepreneur, got married to John Shaw, who is a Scotsman and Indophile. The couple first met in the 1990s when John went to Bangalore to visit the headquarters of Madura Coats. Later after dating for a period of seven years, they tied the knot in 1998.

Kiran Mazumdar Shaw photo
Kiran Mazumdar Shaw photo

Kiran Mazumdar Shaw Career

Likewise, Mazumdar spearheaded Biocon’s evolution from an industrial enzymes manufacturing company to a fully integrated bio-pharmaceutical company along with a well-balanced business portfolio of products and also a research focus on diabetes, oncology a well as auto-immune diseases. In addition, she established two subsidiaries: Syngene in 1994 which provides early research and also development support services on a contract basis and Clinigene in 2000.

Additionally in 1984, Kiran started to develop a research and development team at Biocon, focusing on the discovery of novel enzymes and also on development of novel techniques for solid substrate fermentation technology. Later, the company’s first enabled expansion came in 1987, when Narayanan Vaghul of ICICI Ventures creation of a venture capital fund of US$250,000.

Mazumdar incorporated Biocon Biopharmaceuticals Private Limited (BBLP) to manufacture and also market a select range of biotherapeutics in a joint venture along with the Cuban Center of Molecular Immunology in 1990.

Health

known Rural areas in India are estimated to host only one doctor for every two thousand people, it is also estimated that 70 million people lack money to pay for a doctor’s visit or for medicine. In addition, the Biocon Foundation is involved in several health and education outreach platforms to benefit the economically weaker sections of Indian society.

Infrastructure

Mazumdar-Shaw as well speaks about the importance of improving India’s infrastructure, focusing on the need to address issues including efficient governance, job creation, and food, water, and also health insecurity.

Biocon, Infosys and also other companies have had a significant results on Bengaluru. Likewise, these companies attract several scientists who would otherwise go overseas.

Honorary degrees

In 2004, Mazumdar-Shaw earned an honorary doctorate from her alma mater, Ballarat University, in recognition of her contributions to biotechnology. In addition, she has been awarded honorary doctorates from the University of Abertay, Dundee, UK in 2007, the University of Glasgow, UK in 2008, Heriot-Watt University, Edinburgh, UK in 2008 and University College Cork, Ireland in 2012. Furthermore, she got an honorary doctorate from Davangere University, India, at its first convocation, in July 2013, besides in recognition of her contribution in the field of biotechnology.

Kiran Mazumdar Shaw’s Net Worth

Mazumdar Shaw has an estimated net worth of $2.41 billion USD.

Twitter

You can find and follow Kiran on Twitter using the account name: @kiranshaw

Tags: No tags

Comments are closed.